Clearside Biomedical, Inc.
CLSDDelisted Dec 8, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001539029
Clearside Biomedical, Inc. was delisted on Dec 8, 2025; its insiders filed their last Form 4 on Feb 24, 2025; 26 institutions reported holding it in 13F filings for Q3 2025, worth $2.18M in total; no superinvestor held it.
Q2 2021 vs. Q1 2021
How the institutions holding Clearside Biomedical, Inc. changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Q2 2021 | Change |
|---|---|---|---|
| Holders | 52 | 53 | +1 |
| Shares | 17.7M | 19.7M | +1.93M (+10.9%) |
| Value | $43.8M | $95.8M | +$51.9M (+118.6%) |
New holders (10)
Institutions that held Clearside Biomedical, Inc. at the end of Q2 2021 but not at the end of Q1 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| ACT Capital Management, LLC | 2,462,500 | $12.0M | 6.16% |
| EAM Investors, LLC | 247,561 | $1.21M | 0.19% |
| Ameritas Investment Company, LLC | 50,810 | $247.0K | 0.01% |
| Caxton Associates LP | 24,677 | $120.0K | 0.02% |
| Walleye Capital LLC | 18,000 | $88.0K | 0.00% |
| Goldman Sachs Group Inc | 16,766 | $82.0K | 0.00% |
| Wolverine Trading, LLC | 15,910 | $76.0K | 0.00% |
| Vestor Capital, LLC | 9,000 | $44.0K | 0.00% |
| Cutler Group LP | 3,500 | $17.0K | 0.00% |
| Harbour Investments, Inc. | 400 | $2.00K | 0.00% |
Sold out (9)
Institutions that held Clearside Biomedical, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.
| Institution | Shares, Q1 2021 | Value, Q1 2021 |
|---|---|---|
| Tekla Capital Management LLC | 165,330 | $408.0K |
| Assenagon Asset Management S.A. | 121,317 | $300.0K |
| Newman Dignan & Sheerar, Inc. | 23,023 | $57.0K |
| ExodusPoint Capital Management, LP | 19,885 | $49.0K |
| Qube Research & Technologies Ltd | 18,206 | $45.0K |
| Barclays PLC | 17,045 | $42.0K |
| Tower Research Capital LLC (TRC) | 16,672 | $41.0K |
| Federated Hermes, Inc. | 812 | $2.00K |
| Wealthcare Advisory Partners LLC | 800 | $2.00K |